NO862199L - N- (2-aminoacylamdino-2-desoksy-heksosyl)-amider, -karbamater og urinstoffer, fremgangsmaate til deres fremstilling, samt deres anvendelse i legemidler. - Google Patents

N- (2-aminoacylamdino-2-desoksy-heksosyl)-amider, -karbamater og urinstoffer, fremgangsmaate til deres fremstilling, samt deres anvendelse i legemidler.

Info

Publication number
NO862199L
NO862199L NO862199A NO862199A NO862199L NO 862199 L NO862199 L NO 862199L NO 862199 A NO862199 A NO 862199A NO 862199 A NO862199 A NO 862199A NO 862199 L NO862199 L NO 862199L
Authority
NO
Norway
Prior art keywords
denotes hydrogen
carbon atoms
alkyl radical
hydrogen
aminoacylamdino
Prior art date
Application number
NO862199A
Other languages
English (en)
Other versions
NO166002B (no
NO862199D0 (no
NO166002C (no
Inventor
Oswald Lockhoff
Yutaka Hayauchi
Peter Stadler
Klaus Georg Stuenkel
Gert Streissle
Arnold Paessens
Volker Klimetzek
Hans-Joachim Zeiler
Karl-Georg Metzger
Hein-Peter Kroll
Helmut Brunner
Klaus Schaller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO862199D0 publication Critical patent/NO862199D0/no
Publication of NO862199L publication Critical patent/NO862199L/no
Publication of NO166002B publication Critical patent/NO166002B/no
Publication of NO166002C publication Critical patent/NO166002C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO862199A 1985-06-20 1986-06-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2-aminoacylamido-2-desoksy-heksosyl)-amider, -karbamater og -urinstoffer. NO166002C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853521994 DE3521994A1 (de) 1985-06-20 1985-06-20 N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (4)

Publication Number Publication Date
NO862199D0 NO862199D0 (no) 1986-06-03
NO862199L true NO862199L (no) 1986-12-22
NO166002B NO166002B (no) 1991-02-04
NO166002C NO166002C (no) 1991-05-15

Family

ID=6273684

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862199A NO166002C (no) 1985-06-20 1986-06-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2-aminoacylamido-2-desoksy-heksosyl)-amider, -karbamater og -urinstoffer.

Country Status (21)

Country Link
US (1) US4855283A (no)
EP (1) EP0206037B1 (no)
JP (1) JPH07116207B2 (no)
KR (1) KR930011281B1 (no)
CN (1) CN86104185A (no)
AT (1) ATE71631T1 (no)
AU (1) AU564222B2 (no)
CA (1) CA1289952C (no)
CS (1) CS270209B2 (no)
DE (2) DE3521994A1 (no)
DK (1) DK287886A (no)
ES (2) ES8801769A1 (no)
FI (1) FI84833C (no)
GR (1) GR861574B (no)
HU (1) HU206123B (no)
IE (1) IE58918B1 (no)
IL (1) IL79126A (no)
NO (1) NO166002C (no)
PH (1) PH26775A (no)
PT (1) PT82796B (no)
ZA (1) ZA864571B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3812681A1 (de) * 1988-04-16 1989-11-02 Bayer Ag Substituierte n-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5977336A (en) * 1993-03-16 1999-11-02 St. Louis University High molecular weight surface proteins of non-typeable haemophilus
DK0716658T3 (da) * 1993-08-30 1997-12-22 Bayer Ag Glycosylamider af 2-aminocylamino-2-desoxysukkerarter
US6361779B1 (en) 1993-11-08 2002-03-26 Aventis Pasteur Limited Transferrin receptor genes
CA2175332C (en) 1993-11-08 2009-04-07 Sheena M. Loosmore Haemophilus transferrin receptor genes
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6440425B1 (en) 1995-05-01 2002-08-27 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US6335018B1 (en) * 1995-05-01 2002-01-01 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
ATE496634T1 (de) 1995-05-04 2011-02-15 Sanofi Pasteur Ltd Azelluläre pertussis-impfstoffe und verfahren zu deren herstellung
US5827654A (en) * 1995-05-08 1998-10-27 University Of Toronto Basal body rod protein genes of campylobacter
US5780606A (en) * 1995-06-07 1998-07-14 Connaught Laboratories Limited Neisseria meningitidis capsular polysaccharide conjugates
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
US6290971B1 (en) * 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein
FR2746643B1 (fr) * 1996-04-01 1998-06-12 Techni Pharma Nouvelles compositions laxatives et leur procede de fabrication
DE69736709T2 (de) 1996-07-02 2007-10-04 Sanofi Pasteur Ltd., Toronto Vielwertige dtp-polio-impfstoffe
US6042820A (en) 1996-12-20 2000-03-28 Connaught Laboratories Limited Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
CA2287976A1 (fr) * 1997-04-30 1998-11-05 Bruno Guy Composition vaccinale anti-helicobacter comprenant un adjuvant de type th1
FR2762788B1 (fr) * 1997-04-30 2000-10-06 Pasteur Merieux Serums Vacc Composition vaccinale anti-helicobacter pour usage par voie systemique sous-diaphragmatique
FR2762787B1 (fr) * 1997-04-30 2000-10-06 Pasteur Merieux Serums Vacc Composition vaccinale anti-helicobacter comprenant un adjuvant de type th1
US5977337A (en) 1997-06-03 1999-11-02 Connaught Laboratories Limited Lactoferrin receptor genes of Moraxella
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US7785609B1 (en) 1999-03-16 2010-08-31 Sanofi Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
US6335182B1 (en) 1999-03-16 2002-01-01 Aventis Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
US7241449B1 (en) 1999-04-12 2007-07-10 Aventis Pasteur Limited Transferrin receptor genes of moraxella
CA2388337C (en) 1999-10-22 2013-01-08 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
DK1282702T3 (da) 2000-05-10 2007-04-02 Sanofi Pasteur Ltd Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf
AUPS143402A0 (en) * 2002-03-28 2002-05-09 Alchemia Pty Ltd Anomeric derivatives of monosaccharides
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
SI1567191T1 (sl) * 2002-11-26 2011-01-31 Eurocine Vaccines Ab Novi adjuvans na aminski osnovi
PL2361928T3 (pl) 2003-05-19 2017-09-29 Prothena Biosciences Limited Skrócone fragmenty alfa-synukleiny w chorobie z ciałami Lewy'ego
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
EA013752B1 (ru) 2004-08-09 2010-06-30 Элан Фармасьютикалз, Инк. Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
SI1991266T1 (sl) * 2006-01-26 2013-10-30 Zoetis P Llc Novi sestavki glikolipidnih adjuvansov
CA2634888C (en) * 2006-01-26 2016-06-21 Pfizer Products Inc. Novel glycolipid adjuvant compositions
PL2583978T3 (pl) 2007-02-23 2016-07-29 Prothena Biosciences Ltd Co Profilaktyka i leczenie chorób synukleinopatycznych i amyloidogennych
HUE043966T2 (hu) 2007-02-23 2019-09-30 Prothena Biosciences Ltd Szinukleinopátiás és amiloidogén betegség megelõzése és kezelése
GB2450088A (en) * 2007-06-11 2008-12-17 Diosamine Dev Corp Optionally modified monosaccharides with imine/iminium or glycosidic amine/ammonium group for use in modifying the level of cytokines & in therapy
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
DK2237803T3 (en) 2007-12-28 2015-10-05 Prothena Biosciences Ltd Treatment and prophylaxis of amyloidosis
EP2196196A1 (en) 2008-12-10 2010-06-16 Medipol S.A. Compound, medicament, vaccine composition and nanocapsules
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination
AU2011252844B2 (en) 2010-05-14 2014-07-03 Baxalta GmbH Chimeric OspA genes, proteins, and methods of use thereof
AU2013293448A1 (en) 2012-07-27 2015-02-05 Baxalta GmbH Compositions comprising chimeric OspA molecules and methods of use thereof
CN104628802B (zh) * 2013-11-07 2017-01-18 北大方正集团有限公司 从发酵液中提取并纯化尼莫克汀的方法
JP2017501848A (ja) 2013-11-19 2017-01-19 プロセナ バイオサイエンシーズ リミテッド 便秘症状からのレビー小体病の免疫療法のモニター
EP3028711A1 (en) * 2014-12-05 2016-06-08 Gubra ApS Molecular building blocks capable of assembling carbohydrate derivatives, fatty acid residues and peptides
EP3325015B1 (en) * 2015-07-20 2021-05-12 Zoetis Services LLC Liposomal adjuvant compositions
US10456459B2 (en) * 2015-07-20 2019-10-29 Zoetis Services Llc Liposomal adjuvant compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213650A1 (de) * 1982-04-14 1983-10-27 Bayer Ag, 5090 Leverkusen N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr
DE3344257A1 (de) * 1983-12-07 1985-06-13 Bayer Ag, 5090 Leverkusen Substituierte o-acyl-glycosylamide, verfahren zu iherer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
FI862619A0 (fi) 1986-06-18
FI84833C (fi) 1992-01-27
EP0206037A3 (en) 1988-02-03
HU206123B (en) 1992-08-28
PT82796A (en) 1986-07-01
DE3521994A1 (de) 1987-01-02
US4855283A (en) 1989-08-08
KR870000354A (ko) 1987-02-18
IL79126A (en) 1991-09-16
GR861574B (en) 1986-10-17
NO166002B (no) 1991-02-04
JPS61293991A (ja) 1986-12-24
AU564222B2 (en) 1987-08-06
ES557729A0 (es) 1989-04-16
JPH07116207B2 (ja) 1995-12-13
FI84833B (fi) 1991-10-15
EP0206037A2 (de) 1986-12-30
CS451386A2 (en) 1989-10-13
KR930011281B1 (en) 1993-11-29
NO862199D0 (no) 1986-06-03
ATE71631T1 (de) 1992-02-15
CA1289952C (en) 1991-10-01
AU5897986A (en) 1986-12-24
NO166002C (no) 1991-05-15
IE861636L (en) 1986-12-20
IE58918B1 (en) 1993-12-01
PH26775A (en) 1992-10-13
DE3683410D1 (de) 1992-02-27
DK287886A (da) 1986-12-21
PT82796B (pt) 1988-12-15
ES8900231A1 (es) 1989-04-16
ES8801769A1 (es) 1988-02-16
FI862619A7 (fi) 1986-12-21
ZA864571B (en) 1987-02-25
CN86104185A (zh) 1987-04-08
DK287886D0 (da) 1986-06-19
EP0206037B1 (de) 1992-01-15
CS270209B2 (en) 1990-06-13
HUT41049A (en) 1987-03-30
ES556287A0 (es) 1988-02-16
IL79126A0 (en) 1986-09-30

Similar Documents

Publication Publication Date Title
NO862199L (no) N- (2-aminoacylamdino-2-desoksy-heksosyl)-amider, -karbamater og urinstoffer, fremgangsmaate til deres fremstilling, samt deres anvendelse i legemidler.
NO940592D0 (no) Peptider med vekst-hormon frigjörende aktivitet
MX9203744A (es) Analogos de camptotecina solubles en agua utiles para inhibir el crecimiento de celulas de tumor de animal.
DK138283A (da) Spiro(4.(3+n))-2-aza-3-carboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt midler indeholdende disse forbindelser og deres anvendelse
NO920122D0 (no) Nye tetrazolderivater, deres fremstilling og anvendelse
DK499088A (da) 1-oe(2-pyrimidinyl)-aminoalkylaapiperidinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater
DK0484223T3 (da) 3-cyclopropanamider, deres tautomere former og deres salte samt en fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og præparater med indhold deraf
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
DK225985A (da) Cephalosporiner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler
DK0609310T3 (da) N-(mercaptoacyl)aminosyrer, fremgangsmåder til fremstilling og terapeutisk anvendelse deraf og farmaceutiske sammensætninge
ES485828A1 (es) Procedimiento para la preparacion de piridazinas substitui- das
DK95081A (da) Carboxylsyreamidiner samt deres fremstilling og anvendelse i farmaceutiske praeparater
ES8707499A1 (es) Un metodo para preparar derivados de indol
FR2455037A1 (fr) Medicament freinateur des activites hypophysaires